Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.6900
+0.0020 (0.29%)
At close: May 23, 2025, 4:00 PM
0.6887
-0.0013 (-0.19%)
After-hours: May 23, 2025, 4:00 PM EDT
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $42.07 million as of May 23, 2025. Its market cap has decreased by -32.69% in one year.
Market Cap
42.07M
Enterprise Value
-33.58M
1-Year Change
-32.69%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $42.07M, a decrease of -95.80%. That is a compound annual growth rate of -49.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 41.99M | -26.75% |
| Dec 31, 2024 | 57.32M | -21.36% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.46B |
| Johnson & Johnson | 369.21B |
| AbbVie | 321.45B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 275.16B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 219.90B |
| AstraZeneca | 218.71B |